Cargando…

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

BACKGROUND: Endometrial cancer (EC) is a major health concern due to its rising incidence. Whilst early stage disease is generally cured by surgery, advanced EC has a poor prognosis with limited treatment options. Altered energy metabolism is a hallmark of malignancy. Cancer cells drive tumour growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Latif, Ayşe, Chadwick, Amy L., Kitson, Sarah J., Gregson, Hannah J., Sivalingam, Vanitha N., Bolton, James, McVey, Rhona J., Roberts, Stephen A., Marshall, Kay M., Williams, Kaye J., Stratford, Ian J., Crosbie, Emma J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745908/ https://www.ncbi.nlm.nih.gov/pubmed/29299023 http://dx.doi.org/10.1186/s12907-017-0067-7

Ejemplares similares

Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
por: Sivalingam, Vanitha N., et al.
Publicado: (2019)

Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
por: Kitson, Sarah, et al.
Publicado: (2017)

Optimization of Window Study Endpoints in Endometrial Cancer
por: Kitson, Sarah J., et al.
Publicado: (2019)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Monocarboxylate Transporter 1 (MCT1) Mediates Succinate Export in the Retina
por: Bisbach, Celia M., et al.
Publicado: (2022)

High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer
por: Kitson, Sarah J., et al.
Publicado: (2018)

Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome
por: Atiomo, William, et al.
Publicado: (2017)

Measuring the biological effect of presurgical metformin treatment in endometrial cancer
por: Sivalingam, V N, et al.
Publicado: (2016)

The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study
por: Ryan, Neil A. J., et al.
Publicado: (2020)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
por: Liu, Tian, et al.
Publicado: (2023)

Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome
por: Leu, Martin, et al.
Publicado: (2021)

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer
por: Johnson, Jennifer M., et al.
Publicado: (2017)

Inhibition of monocarboxylate transporters (MCT) 1 and 4 reduces exercise capacity in mice
por: Kitaoka, Yu, et al.
Publicado: (2022)

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
por: Eilertsen, Marte, et al.
Publicado: (2014)

Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC)
por: Jeon, Jeong Yong, et al.
Publicado: (2018)

The Hepatic Monocarboxylate Transporter 1 (MCT1) Contributes to the Regulation of Food Anticipation in Mice
por: Martini, Tomaz, et al.
Publicado: (2021)

AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7–10
por: Ovens, Matthew J., et al.
Publicado: (2010)

Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study
por: Paraskevaidi, Maria, et al.
Publicado: (2020)

BRCA and lynch syndrome-associated ovarian cancers behave differently
por: Ryan, Neil A.J., et al.
Publicado: (2017)

The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study
por: Kitson, Sarah J., et al.
Publicado: (2018)

High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021)

Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
por: Liu, Yannan, et al.
Publicado: (2019)

Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy
por: Thomas, Jinsu, et al.
Publicado: (2023)

Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2021)

The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein
por: Ovens, Matthew J., et al.
Publicado: (2010)

TMEM67, TMEM237, and Embigin in Complex With Monocarboxylate Transporter MCT1 Are Unique Components of the Photoreceptor Outer Segment Plasma Membrane
por: Skiba, Nikolai P., et al.
Publicado: (2021)

Inhibition of the Monocarboxylate Transporter 1 (MCT1) Promotes 3T3-L1 Adipocyte Proliferation and Enhances Insulin Sensitivity
por: Bailey, Tracey, et al.
Publicado: (2022)

Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2020)

Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
por: Mehibel, Manal, et al.
Publicado: (2018)

Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers
por: Evans, D Gareth, et al.
Publicado: (2022)

Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4)
por: Ziegler, Kerstin, et al.
Publicado: (2016)

Impact of the Monocarboxylate Transporter-1 (MCT1)-Mediated Cellular Import of Lactate on Stemness Properties of Human Pancreatic Adenocarcinoma Cells †
por: Sandforth, Leontine, et al.
Publicado: (2020)

Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
por: Puri, Sachin, et al.
Publicado: (2022)

Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination
por: Lee, Jae Young, et al.
Publicado: (2017)

Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer
por: Bisetto, Sara, et al.
Publicado: (2018)

Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization
por: Pinheiro, Céline, et al.
Publicado: (2014)

Altered mRNA and Protein Expression of Monocarboxylate Transporter MCT1 in the Cerebral Cortex and Cerebellum of Prion Protein Knockout Mice
por: Ramljak, Sanja, et al.
Publicado: (2021)

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011)

The Neuroplastin Adhesion Molecules Are Accessory Proteins That Chaperone the Monocarboxylate Transporter MCT2 to the Neuronal Cell Surface
por: Wilson, Marieangela C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8ppk9kig704ol0t8h332ju5l65